Results 1 to 10 of about 3,140 (221)
Stability studies of isohydrafural and fluocinolone acetonide combined ointment [PDF]
The Moldovan Medical Journal, 2020 Background: The isohydrafural and fluocinolone acetonide combined ointment contributes to the diversification of the treatment of dermatitis and psoriasis associated with bacterial infections.
Elena Donici +2 more
doaj +5 more sources
Scleral fixation of fluocinolone acetonide implant
American Journal of Ophthalmology Case Reports, 2020 Purpose: To report on the technique of scleral fixation of fluocinolone acetonide (FAc) implant in 2 eyes with recalcitrant diabetic macular edema (DME). Observations: Two eyes of 2 patients with persistent DME, partially responsive to anti-VEGF therapy,
Homayoun Tabandeh, Kourous Rezaei
doaj +4 more sources
Intravitreal Fluocinolone Acetonide for Diabetic Macular Edema: Long-Term Effect and Structure/Function Correlation [PDF]
, 2022 The long-term effect of intravitreal Fluocinolone acetonide (FAc) on retinal morphology and function in diabetic macular edema (DME) was investigated. Seventeen eyes of twelve consecutive DME patients, treated by intravitreal FAc, were retrospectively ...
Falsini, Benedetto (ORCID:0000-0002-3569-4968) +4 more
core +3 more sources
Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience [PDF]
Scientific Reports, 2021 We conducted a meta-analysis of real-world studies on the 0.19 mg Fluocinolone Acetonide (FAc) intravitreal implant for chronic diabetic macular oedema (DMO), comparing these findings with the Fluocinolone Acetonide for Diabetic Macular Edema (FAME ...
Matteo Fallico +14 more
doaj +2 more sources
Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes [PDF]
International Journal of Ophthalmology, 2018 AIM: To report real-life data on the use of an intravitreal fluocinolone acetonide implant in the treatment of refractory diabetic macular edema (DME) in pars plana vitrectomized (PPV) and non-PPV eyes.
Alberto La Mantia +4 more
doaj +2 more sources
Prognostic biomarkers of chronic diabetic macular edema treated with a fluocinolone acetonide intravitreal implant [PDF]
, 2021 Background: This study aimed to investigate retinal imaging biomarkers, such as disorganization of the retinal inner layers (DRIL) and/or ellipsoid zone (EZ) disruption by spectral domain optical coherence tomography (SD-OCT), and functional outcomes in ...
Aerts , Florence +5 more
core +3 more sources
Recurrent Diabetic Macular Edema: What to Do [PDF]
Case Reports in Ophthalmology, 2017 Diabetic macular edema (DME) is a leading cause of blindness in the working population. Herein, we report the case of a patient with recurrent DME for about 6 years, uncontrolled by several medical and surgical treatments, that was successfully treated ...
Rita Santos Gonçalves +2 more
doaj +3 more sources
Clinical Ophthalmology, 2012 John D Sheppard Jr1, Quan Dong Nguyen2, Dale W Usner3, Timothy L Comstock3, for the Fluocinolone Acetonide Uveitis Study Group1Eastern Virginia Medical School, Norfolk, VA, USA; 2Wilmer Ophthalmological Institute, Johns Hopkins University, Baltimore, MD,
Sheppard Jr JD +3 more
doaj +3 more sources
Journal of Cosmetic Dermatology, Volume 24, Issue 5, May 2025.ABSTRACT Background Treatment with fluocinolone acetonide, hydroquinone, and tretinoin cream is the gold standard for melasma; however, the effects of this treatment in the Chinese population remain unclear. Due to the differences between Chinese and Caucasian subjects, further clinical trials in Chinese patients with melasma are needed.
Honghua Hu +7 more
openalex +2 more sources
Materials & Design, 2023 Engineered tissue currently lacks requisite capacity to sustain cell viability and functionality. Here we demonstrate that human RPE cell lines (ARPE-19) can be cultured on ultrathin suspended electrospun nanofibre scaffolds (ENS) composed of hydrophobic
Biola F. Egbowon +6 more
doaj +2 more sources